Literature DB >> 15910767

Anti-hyperalgesic effects of intrathecally administered neuropeptide W-23, and neuropeptide B, in tests of inflammatory pain in rats.

Tatsuo Yamamoto1, Osamu Saito, Koyo Shono, Serabi Tanabe.   

Abstract

Neuropeptide W-23 (NPW23) is an endogenous ligand of both GPR7 and GPR8, and neuropeptide B (NPB) is an endogenous ligand of GPR7. GPR7 mRNA has been detected in regions of the cortex, the hippocampus, the hypothalamus, and the spinal cord in the rat, but GPR8 has not been found in rodents. GPR7 and GPR8 receptors have structural features in common with both opioid and somatostatin receptors. The effects of intrathecal (i.t.) application of NPW23 and NPB were tested in two inflammatory pain models (plantar injection of formalin or carrageenan) and two thermal nociceptive tests (52.5 degrees C and 50.5 degrees C hot plates) and one mechanical nociceptive test in the rat. I.t. injection of either NPW23 or NPB decreased the number of agitation behaviors induced by paw formalin injection and attenuated the level of mechanical allodynia, but not the level of thermal hyperalgesia, induced by paw carrageenan injection in a dose-dependent manner at a dose between 0.1 and 10 microg, significantly. The effects of either 10 microg of NPW23 or 10 microg of NPB were not antagonized by 10 microg of naloxone. I.t. injection of either NPW23 or NPB had no effect in both the 52.5 degrees C hot plate test or in the 50.5 degrees C hot plate tests at a dose between 1 and 100 microg. I.t. injection of either 10 microg of NPW23 or 10 microg of NPB had no effect in the mechanical nociceptive test. I.t. injection of either 10 microg of NPW23 or 10 microg of NPB significantly suppressed the expression of Fos-like immunoreactivity of the L4-5 spinal dorsal horn induced by paw formalin injection. These data suggest that both spinally-applied NPW23 and NPB suppressed the input of nociceptive information to the spinal dorsal horn, produced an analgesic effect in the formalin test, and attenuated the level of mechanical allodynia in the carrageenan test, and that either spinally applied NPW23 or spinally applied NPB had no effect in the physiological condition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15910767     DOI: 10.1016/j.brainres.2005.03.027

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  In search of analgesia: emerging roles of GPCRs in pain.

Authors:  Laura S Stone; Derek C Molliver
Journal:  Mol Interv       Date:  2009-10

Review 2.  Analgesic neuropeptide W suppresses seizures in the brain revealed by rational repositioning and peptide engineering.

Authors:  Brad R Green; Misty Smith; Karen L White; H Steve White; Grzegorz Bulaj
Journal:  ACS Chem Neurosci       Date:  2010-11-18       Impact factor: 4.418

3.  Neuropeptide B-deficient mice demonstrate hyperalgesia in response to inflammatory pain.

Authors:  Michele A Kelly; Carsten T Beuckmann; S Clay Williams; Christopher M Sinton; Toshiyuki Motoike; James A Richardson; Robert E Hammer; Mary G Garry; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-27       Impact factor: 11.205

Review 4.  Neuropeptide B and W: neurotransmitters in an emerging G-protein-coupled receptor system.

Authors:  Gurminder Singh; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2006-07-17       Impact factor: 8.739

5.  Design, synthesis and SAR analysis of novel potent and selective small molecule antagonists of NPBWR1 (GPR7).

Authors:  Mariangela Urbano; Miguel Guerrero; Jian Zhao; Subash Velaparthi; S Adrian Saldanha; Peter Chase; Zhiwei Wang; Olivier Civelli; Peter Hodder; Marie-Therese Schaeffer; Steven Brown; Hugh Rosen; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2012-10-02       Impact factor: 2.823

6.  SAR analysis of novel non-peptidic NPBWR1 (GPR7) antagonists.

Authors:  Miguel Guerrero; Mariangela Urbano; Marie-Therese Schaeffer; Steven Brown; Hugh Rosen; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2012-12-20       Impact factor: 2.823

7.  Neuropeptide B/W receptor 1 peptidomimetic agonists: Structure-activity relationships and plasma stability.

Authors:  Thuy Nguyen; Ann M Decker; Rodney W Snyder; Emma C Tonetti; Thomas F Gamage; Yanan Zhang
Journal:  Eur J Med Chem       Date:  2022-01-21       Impact factor: 6.514

8.  Neuropeptide W Attenuates Oxidative Multi-Organ Injury in Rats Induced with Intra-Abdominal Sepsis.

Authors:  Ali Emre Atici; Sevil Arabacı Tamer; Hilal Nişva Levent; İrem Peker Eyüboğlu; Feriha Ercan; Mustafa Akkiprik; Berrak Ç Yeğen
Journal:  Inflammation       Date:  2021-09-25       Impact factor: 4.092

9.  Transcriptional profile of spinal dynorphin-lineage interneurons in the developing mouse.

Authors:  Elizabeth K Serafin; Alexander Chamessian; Jie Li; Xiang Zhang; Amanda McGann; Chelsie L Brewer; Temugin Berta; Mark Baccei
Journal:  Pain       Date:  2019-10       Impact factor: 7.926

10.  NPBWR1 and NPBWR2: Implications in Energy Homeostasis, Pain, and Emotion.

Authors:  Takeshi Sakurai
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.